Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
On-road driving performance with solriamfetol in adults with narcolepsy
2015-003931-36Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Jan 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of solriamfetol in narcolepsy, sponsored by Jazz Pharmaceuticals plc. Primary endpoints: Driving performance and Safety and tolerability. Started Jan 2016; status: completed.
02
Drugs
solriamfetol
03
Conditions
narcolepsy
Beyond the preview
Go deeper on 2015-003931-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003931-36.